"REAL WORLD" DATA FROM PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO HAVE BEEN TREATED WITH LENALIDOMIDE AND DEXAMETHASONE, ACCORDING TO THE STANDARD CLINICAL PRACTICE

被引：0

作者：

Katodritou, E. ^{[1
]}

Anagnostopoulos, A. ^{[2
]}

Vadikolia, C. ^{[2
]}

Lalayianni, C. ^{[2
]}

Kotsopoulou, M. ^{[3
]}

Repousis, P. ^{[3
]}

Megalakaki, A. ^{[3
]}

Rekleiti, A. ^{[3
]}

Dadakaridou, M. ^{[3
]}

Papageorgiou, G. ^{[3
]}

Kyrtsonis, M. ^{[4
]}

Matsouka, P. ^{[5
]}

Giannakoulas, N. ^{[5
]}

Kyriakou, D. ^{[5
]}

Karras, G. ^{[5
]}

Anagnostopoulos, N. ^{[6
]}

Michalis, E. ^{[6
]}

Briasoulis, E. ^{[7
]}

Hatzimichael, E. ^{[7
]}

Spanoudakis, E. ^{[8
]}

Zikos, P. ^{[9
]}

Tsakiridou, A. ^{[9
]}

Tsionos, K. ^{[10
]}

Anargyrou, K. ^{[11
]}

Symeonidis, A. ^{[12
]}

Maniati, A. ^{[13
]}

Terpos, E. ^{[14
]}

机构：

[1] Theagen Canc Hosp, Dept Hematol, Thessaloniki, Greece

[2] George Papanikolaou Gen Hosp, Hematol Dept, Thessaloniki, Greece

[3] Gen Anticancer Hosp Metaxa, Hematol Dept, Athens, Greece

[4] Gen Hosp Athens Laiko, Hematol Dept, Athens, Greece

[5] Univ Gen Hosp Larissa, Hematol Dept, Larisa, Greece

[6] Gen Hosp Athens G Gennimatas, Hematol Dept, Athens, Greece

[7] Univ Gen Hosp Ioannina, Hematol Dept, Ioannina, Greece

[8] Univ Gen Hosp Alexandroupolis, Hematol Dept, Alexandroupolis, Greece

[9] Gen Hosp Patras Agios Andreas, Hematol Dept, Patras, Greece

[10] Gen Airforce Hosp 251, Hematol Dept, Athens, Greece

[11] 251 Gen Airforce Hosp, Dept Hematol, Athens, Greece

[12] Univ Patras, Sch Med, Hematol Div, Patras, Greece

[13] Hosp Errikos Ntynan, Hematol Dept, Athens, Greece

[14] Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece

来源：

HAEMATOLOGICA | 2013年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

B1512

引用

页码：604 / 604

页数：1

共 50 条

[41] Ixazomib/Lenalidomide/Dexamethasone (IRd) in relapsed refractory Multiple Myeloma (RRMM) - retrospective real-world data from Germany and comparison to literature
Roesner, A.
Wenger, S.
Brioli, A.
von Lilienfeld-Toal, M.
Klaiber-Hakimi, M.
Fehr, E. M.
Munder, M.
Epp, K.
Trautmann-Grill, K.
Engelhardt, M.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 235 - 236
[42] Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma
Paludo, Jonas
Mikhael, Joseph R.
LaPlant, Betsy R.
Halvorson, Alese E.
Kumar, Shaji
Gertz, Morie A.
Hayman, Suzanne R.
Buadi, Francis K.
Dispenzieri, Angela
Lust, John A.
Kapoor, Prashant
Leung, Nelson
Russell, Stephen J.
Dingli, David
Go, Ronald S.
Lin, Yi
Gonsalves, Wilson I.
Fonseca, Rafael
Bergsagel, P. Leif
Roy, Vivek
Sher, Taimur
Chanan-Khan, Asher A.
Ailawadhi, Sikander
Stewart, A. Keith
Reeder, Craig B.
Richardson, Paul G.
Rajkumar, S. Vincent
Lacy, Martha Q.
[J]. BLOOD, 2017, 130 (10) : 1198 - 1204
[43] TREATMENT OF MULTIPLE RELAPSED/REFRACTORY MYELOMA WITH LENALIDOMIDE DEXAMETHASONE RETROSPECTIVE ANALYSIS OF 65 PATIENTS TREATED AT A CENTER
Moya Arnao, M.
Cabanas Perianes, V
Moreno Balmonte, M. J.
Martinez Marin, A.
Fernandez Poveda, E.
Navarro Almenzar, B.
Berenguer Piqueras, M.
Salido Fierez, E.
Labbadia, F.
Perez Lopez, R.
Garcia Hernandez, A. M.
Cerezo Manchado, J. J.
Blanquer Blanquer, M.
Martinez Garcia, A. B.
Melero Amor, A.
Garcia Candel, F.
Moraleda Jimenez, J. M.
[J]. HAEMATOLOGICA, 2017, 102 : 97 - +
[44] Erratum: Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
Nikhil C Munshi
Constantine Mitsiades
Paul G Richardson
Kenneth C Anderson
[J]. Nature Clinical Practice Oncology, 2008, 5 : 493 - 493
[45] Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
Shinsuke Iida
Takaaki Chou
Shinichiro Okamoto
Hirokazu Nagai
Kiyohiko Hatake
Hirokazu Murakami
Toshiyuki Takagi
Kazuyuki Shimizu
Henry Lau
Kenichi Takeshita
Masaaki Takatoku
Tomomitsu Hotta
[J]. International Journal of Hematology, 2010, 92 : 118 - 126
[46] Erratum: Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
D S Siegel
P Richardson
M Dimopoulos
P Moreau
C Mitsiades
D Weber
J Houp
C Gause
S Vuocolo
J Eid
T Graef
K C Anderson
[J]. Blood Cancer Journal, 2014, 4 : e202 - e202
[47] "REAL-LIFE" EXPERIENCE OF CARFILZOMIB COMBINED WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS
Antonioli, E.
Staderini, M.
Nozzoli, C.
Guarrera, A. S.
Messeri, M.
Carrai, V.
Puccini, B.
Rigacci, L.
Saccardi, R.
Bosi, A.
[J]. HAEMATOLOGICA, 2017, 102 : 131 - 132
[48] Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
Iida, Shinsuke
Chou, Takaaki
Okamoto, Shinichiro
Nagai, Hirokazu
Hatake, Kiyohiko
Murakami, Hirokazu
Takagi, Toshiyuki
Shimizu, Kazuyuki
Lau, Henry
Takeshita, Kenichi
Takatoku, Masaaki
Hotta, Tomomitsu
[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (01) : 118 - 126
[49] Efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma: a real-life experience
Soyer, Nur
Patir, Pusem
Uysal, Ayse
Duran, Mustafa
Unal, Hatice Demet
Durusoy, Raika
Tombuloglu, Murat
Sahin, Fahri
Tobu, Mahmut
Vural, Filiz
Saydam, Guray
[J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (04) : 777 - 785
[50] Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study
M. Macro
C. Hulin
L. Vincent
A. Charvet-Rumpler
L. Benboubker
C. Calmettes
A.-M. Stoppa
K. Laribi
L. Clement-Filliatre
H. Zerazhi
F. Honeyman
V. Richez
F. Maloisel
L. Karlin
J. Barrak
C. Chouaid
X. Leleu
[J]. Annals of Hematology, 2023, 102 : 2137 - 2151

← 1 2 3 4 5 →